Is Boston Scientific Stock Underperforming the Dow?

The Marlborough, Massachusetts-based Boston Scientific Corporation (BSX) designs and commercializes medical devices that power minimally invasive procedures across cardiovascular, urology, neurology, oncology, and gastrointestinal care. With a market capitalization of about $111.5 billion, the company stands in the “large-cap” territory, a bracket reserved for businesses valued above $10 billion. This scale provides reach, capital flexibility, and a global sales infrastructure that supports hospitals and ...